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.-IBSTRAC’T. Ascites is a readily available source of human macrophages (MO), which can be used to study MI, 
functions in vitro. We characterized the mediators of inflammation produced by human peritoneal MB (hp-MO) 
obtained from patients with portal hypertension and ascites. 
The production of the cytokines interleukin-lp (IL-@), interleukin-6 (IL-6) and tumor necrosis factor-a 
(TNF-a) was found to be lipopolysaccharide (LPS) concentration dependent (O-10 pg/ml) with a maximal 
production at 10 pg/ml and also dependent on the time of exposure to the stimulus (O-36 h). IL-lp, IL-6 and 
TNF-a production after LPS administration reached a plateau at 24 h. 
In vitro stimulation for 24 h with LPS does not influence the eicosanoid production from endogenous 
arachidonate. 13 min of exposure of the cells to the calcium ionophore A23187 gives a significant increase 
in eicosanoid production from both exogenous and endogenous arachidonate. The main eicosanoids produced 
are the 5-lipoxgenase products LTB4 and 5-hydroxyeicosatetraenoic a id (HETE). The increase in production 
of the other eicosanoids is not significant. The eicosanoid production depends on the stimulus concentration. 
The optimal A23187 concentration is 1 PM. 
Oxygen radical production was measured in the Mlr by a flowcytometric method. The fluorescence intensity 
of phorbol 12-myristate 13-acetate stimulated and dihydro-rhodamine 123 loaded hp-Ma increases signi- 
ficantly after 15 min. 
We conclude that LPS stimulation of hp-M0 from liver disease results in similar production of IL-lp, IL-6 
and TNF-a, but that the profile of the eicosanoid production of these MB stimulated with LPS and A23187 
differs from M0 of other origin and species. 
INTRODUCTION 
Macrophages (Ma) are of central importance in the 
imtiation and regulation of non-specific and specific 
immune responses. They take part as active phagocytic 
cells. serve as antigen presenting cells (APC) for T- 
lymphocytes and are a major source of a wide range 
of inflammatory products including eicosanoids and 
qtokines in different types of immune responses 
(e.g. host defence against microorganism, antitumor and 
chronic inflammation). When monocytes or tissue Me 
are stimulated. both develop into active MO. Profound 
changes then occur in morphology and function. Major 
changes are: increase in size, more complex and nu- 
merous surface folds and an increase in the numbers of 
vacuoles, lysosomes. phagosomes and endoplasmatic 
reticular elements. The adhesiveness and expression of 
Ia antigens increases. The M@ become more sensitive for 
agents which trigger oxygen radicals and +y__s_ecrete a
large range of products including enzymes. coagulation 
factors, proteins of complement system. factors regu- 
lating cell activities and proliferation, bioactive lipids. 
nucleotide metabolites and reactive oxygen metabolites 
(1.2). 
In vivo M@ activation appears to be mediated and/or 
modulated by microbial pathogens and their products, 
lipid mediators and cytokines (3. 4). In vitro activation 
can be initiated by a variety of agents. including calcium 
ionophore A23 I X7 (A23 I X7) (5 ), lipopolysaccharide 
(LPS) (6, 7) or cytokines (8. 9). The cytokines interleukin- 
I (IL-1 ) ( IO). interleukin-6 (IL-6) ( I I ) and tumor necrosis 
factor (TNF-a~ ( 12) are important Mti cytokine products 
when stimulated with LPS (7). which is one of the most 
potent stimuli of MC? ( 13). 
184 Prostaglandins Leukotrienes and Essential Fatty Acids 
Arachidonic acid can be metabolized to biologically 
active eicosanoids. The cyclooxygenase pathway gener- 
ates the prostanoids and the 5-lipoxygenase pathway 
produces leukotriene B, (LTB,) and 5-hydroxyeicosa- 
tetraenoic acid (5-HETE) (14, 15). Eicosanoids exhibit 
distinct biological effects (1619). Like the cytokines 
they have an important function in controlling the im- 
mune reaction. A23 187 is one of the most potent stimuli 
of eicosanoid production (5, 20, 21). 
The respiratory burst is a characteristic feature of 
phagocytes. The production and release of radical oxy- 
gen intermediates (ROI) by Mo plays a major role in 
several of the effector functions of these cells. Oxygen 
radicals are of critical importance for antibacterial de- 
fence. They are also involved in tumoricidal activities, 
in suppression of lymphocyte proliferation (22, 23) and 
have been implicated as important mediators of tissue 
damage in inflammation (24, 25). Oxygen radicals may 
be involved in a positive feedback mechanism of inflam- 
mation; superoxide anion (0;) can induce IL-I produc- 
tion in monocytes and polymorphonuclear leucocytes 
(PMNs) (26). 
We have previously isolated human peritoneal Mo 
(hp-Mo) from ascitic fluid, obtained from patients with 
liver cirrhosis to investigate various aspects of their me- 
tabolism and the role of Mo in inflammation (27, 28). 
The aim of this study is to analyze the profile of 
eicosanoid production, the levels of cytokine production 
and the respiratory burst activity in this type of hp-Mo, 
regarding the potential influence of liver disease on 
these parameters, in comparison with other types of 
MB. 
MATERIALS AND METHODS 
Subjects 
The hp-Mo were obtained from ascitic fluid of 12 pa- 
tients with liver cirrhosis. 2 patients with congestive 
heart failure, 1 patient with primary slcerosing cholangitis, 
1 patient with malignant mesothelioma and 1 patient 
with the Budd-Chiari syndrome (Table 1). None of the 
patients were on drugs which have been reported to in- 
fluence the lipoxygenase and cyclooxygenase enzymes. 
Cell isolation 
The hp-cells were isolated by centrifugation of the 
ascitic fluid at 400xg (4°C) and washed with phosphate 
buffered saline (PBS, pH 7.4, 4°C Oxoid, UK). The 
concentrated hp-cell suspension was separated on Percoll 
(d = 1.064 g/ml, Kabi-Pharmacia, Sweden). A small 
sample of cells was stained by Hemacolor (Merck, 
Germany) and the different cell types were counted 
under a microscope (Zeiss, standard 25, Germany). 
The viability of the cells was tested by trypan blue 
exclusion. 
Table 1 List of patients with ascites (n = 17) 
Number m/f age Diagnosis 
2. 
5. 
6. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
male 68 biliary liver cirrhosis 
male 65 congestive heart failure 
female 50 alcoholic hepatitis and liver cirrhosis 
female 12 alcoholic liver cirrhosis 
male 69 alcoholic liver cirrhosis 
female 14 alcoholic liver cirrhosis 
female 65 alcoholic liver cirrhosis 
male 69 congestive heart failure 
female 38 Budd- Chiari syndrome 
male 46 alcoholic liver cirrhosis 
male 65 cryptogenic liver cirrhosis 
male 59 alcoholic liver cirrhosis 
male 60 alcoholic liver cirrhosis 
male 39 primary sclerosing cholangitis 
female 42 alcoholic liver cirrhosis 
male 39 alcoholic liver cirrhosis 
male 82 malignant mesothelioma 
Cytokine production 
For the measurement of the cytokine production one 
million leucocytes per ml RPM1 (RPMI-1640 + HEPES 
(GIBCO, UK) + penicillin/streptomycin (5 x lo4 p/l / 
50 mg/l, Flow Lab, UK) + foetal calf serum (FCS) (10% 
FCS, GIBCO, UK) + L-glutamine (600 mg/l Flow Lab, 
UK)) were plated on plastic culture dishes (Costar, UK). 
The cells were stimulated with the addition of increasing 
concentrations of lipopolysaccharide (O-10 pg/ml, 36 h, 
LPS from E. coli 011 l:B4 in PBS, Sigma, USA) or incu- 
bated in the absence or presence of LPS (10 pg/mll for 
an increasing time period (O-36 h, 37”C, 7.5% CO?). As 
blanc PBS was added. The net cytokine production is 
the production with LPS minus blanc of cells incubated 
for the same period of time. At the end of the incubation 
the supernatant was filtered (0.22 pm, Millipore, France) 
and kept at -70°C till analyzing. IL-lb and IL-6 produc- 
tion in the supematant of the samples were measured 
by ELISA (IL-lfi: Medgenix, Belgium, IL-6: Hycult, 
Holland). Tumour necrosis factor-a (TNF-a) production 
of the samples was determined with a bioassay and 
partly by ELISA (Cistron, USA). For this bioassay the 
TNF-a sensitive cell line WEHI- was used. The 
WEHI- 164 cells were plated out in 96-wells plates (2 x 
IO4 cells/50 pi/well, Costar, UK) and the samples (50 pl/ 
well) or the human recombinant TNF-a (hr-TNF-a) 
standards (0.1-1000 p/ml hr-TNF-a, 50 @/well) were 
added. After 24 h of incubation (37°C 7.5% CO?), MTT 
(Tetrazolium salt, Sigma, USA) was added (0.125 mg/ 
well) and after an incubation of 3 h the cells were lysed 
with buffer (20% sodium dodecyl sulphate (SDS) in 
50% N,N-dimethylformamide (DMF), pH 4.7, 100 pl/ 
well) during 18 h. The absorbance was measured at 
595 nm with an ELISA-reader (BIO RAD, model 3550, 
UK). The TNF-cr production by hp-Mo is expressed as 
the cytotoxicity against WEHI- cells compared to 
blanc (RPM1 complete) (29). 
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Eicosanoid production 
For the measurement of eicosanoid production from 
exogenous arachidonate, I x lo6 leucocytes per ml PBS 
(+ Ca’+. pH 7.4, Oxoid, UK) in polypropylene tubes 
(Greiner, The Netherlands) were labelled with 14C- 
arachidonic acid t “‘C-AA) (0.125 pCi, 55.7 MCilmmol, 
Amersham, UK) for 2 min and triggered by A23 187 
(O-5 pM final concentration in dimethylsulfoxide 
(DMSO, Sigma, USA) for 13 min at 37°C. Controls 
were incubated with DMSO. “H-labelled standards con- 
sisting of 6kPGF,,, prostaglandin EZ (PGE,), leukotriene 
B1 (LTB,). 12-HETE and 15-HETE (approximately 
0.01 pCi of each eicosanoid, Amersham, UK) were 
added for recovery calculations and as retention time 
markers. The supernatants were then passed through Sep 
Pak C,, cartridges (Waters Ass., USA) and eluted with 
methanol. dried and dissolved in 200 1.11 methanol. 
Eicosanoid formation was measured on RP-HPLC using 
a Nucleosil 5C,% column (3 x 200 mm), Chrompak, The 
Netherlands). 100 pl sample was injected onto the 
coiumn. As eluens a gradient of acetonitrile and 0.2% 
triethylamine/O. 132% trifluoracetic acid/water (pH > > 3) 
was used. The eicosanoid formation is expressed as 
the mean % of total formation of the most common 
metabolites per patient. In these samples. both A23187 
stimulated and non-stimulated, eicosanoid production 
horn endogenous arachidonate was measured (LTB4, 
PGE,, thromboxane BZ (TXB?) and 6kPGF,,). In the 
cytokine samples (24 h, 10 pg/ml LPS In RPMI) also the 
eicosanoid production from endogenous arachidonate 
was measured by radio immuno assays (antibodies were 
obtained from Advanced Magnetics, USA and standards 
from Sigma, USA). The exogenous eicosanoid produc- 
tion is given as net production. This is the production 
of the cells with A23 187 minus control values. 
Respiratory burst activity 
ROI production was measured with dihydrorhodamine 
123 (DHR 123. Molecular probes, USA). The stock so- 
lurion was 1 mg/ml in N,N-dimethylformamide (Sigma, 
USA); further dilution was performed with PBS. DHR 
123 is oxidized intracellularly to fluorescent rhodamine 
123 (R123) by hydrogen peroxide. 
Leucocytes (0.25 x 106/ml) were incubated in RPM1 
in polypropylene tubes with increasing concentrations 
of phorbol 12-myristate 13-acetate (0 - 1000 @ml, 
TPA diluted in DMSO: PBS = l:lO, Sigma, USA, 
l(, min, 37°C blanc is 10% DMSO) directly followed by 
incubations with increasing concentrations of DHR 123 
(0_100ng/ml, 15 min, 37°C). In the time experiments 
TPA and DHR 123 were added to the cells at the same 
time and incubated for an increasing time period (O-l h, 
100 ng/ml TPA, 333 ng/ml DHR 123, 37°C). Samples 
were put on ice straight after the incubations. The fluo- 
rescence intensity (mean channel number (MCN) was 
measured with a fluorescence activating cell scanner 
(FACS, Becton Dickinson Immunocytometry Systems, 
USA). R 123 is detected as Fluorescence 1 (green; 500- 
530 nm) (30, 3 1). 5000 cells per sample were measured. 
The data were evaluated with the FACS SCAN program 
system (Becton Dickinson Immunocytometry Systems, 
USA). The net ROI production is the fluorescence in- 
tensity (in MCN) of the TPA stimulated and DHR 123 
loaded cells, minus the fluorescence intensity (in MCN) 
of the non-stimulated cells which were also loaded with 
DHR 123 and incubated for the same period of time. 
Statistical analysis 
The data are expressed as the mean + SEM. Data were 
statistically analyzed with Anova followed by the 
Student’s t-test or the Student’s t-test only; data were 
considered significant when p < 0.05. 
RESULTS 
Cell differentiation 
The Percoll separated cell suspension was microscopi- 
cally examined and the following composition of cells 
was found: 94.6 + 1.2% Mo, 4.0 + 1.1% lymphocytes 
and 1.2 f 0.4% granulocytes (n = 17 ). The viability of 
the cells was 86 + 1.3% (range: 94.2-75.8). 
Cytokine production 
To determine LPS concentration for optimal IL- 1 p, IL-6 
and TNF-a production, hp-Mo were stimulated with 
increasing concentrations of LPS (O-10 yg/ml) for 36 h 
as shown in Figure 1. The highest production was with 
the highest LPS concentration used. All subsequent 
experiments were performed with 10 pg/ml LPS. 
The time dependent net IL-lb, IL-6 and TNF-a pro- 
duction from O-36 h with LPS is shown in Figure 2. The 
maximal net cytokine production for all three cytokines 
was reached at 24 h. 
The IL-lp (n = 16) IL-6 (n = 10) and TNF-cr (n = lO/ 
17) production without or after stimulation with 10 pg/ 
ml LPS for 24 h is shown in Table 2. LPS stimulation 
resulted in a significant increase in the production of 
each cytokine. Mel from 6 out of 16 patients had no 
IL- 10 production without LPS, all patients had IL-6 pro- 
duction without LPS stimulation and 6 out of IO patients 
had no TNF-a production without LPS. 
Eicosanoid production 
First the A23187 concentration was determined (O-5 PM) 
which yielded the most eicosanoid production. Figure 3 
(top and middle) shows the LTB, and 5-HETE pro- 
duction from added 14C-AA (exogenous production) and 
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Fig. 1 Interleukin-I p (n = 3, ng/ml, top Fig) interleukin-6 (n = 2, ng/ 
ml, middle Fig) and tumor necrosis factor (n = 2.8 killing, bottom 
Fig) production by hp-Mo ( 10h/ml) stimulated with an increasing 
concentration of lipopolysaccharide (LPS): GIO pg/ml. The results 
are shown separately per patient (W. l , A). 
0 12 24 36 
Time (hours) 
0 12 24 36 
Time (hours) 
Fig. 2 The time dependency of net interleukin- 10 (n = 2, @ml, top 
Fig), interleukin-6 (n = 3, ngfml, middle Fig) and tumor necrosis 
factor (% killing, n = 3. bottom Fig) production of hp-Mo (lO”/ml) 
stimulated with 10 pg/ml lipopolysaccharide (LPS). The cells were 
stimulated for O-36 h. The results are shown separately per patient 
(U, 0. A). 
Figure 3 (bottom) the endogenous LTB4 production 3A. The main net eicosanoids were the 5-lipoxygenase 
as measured by radioimmunoassay (RIA) of 3 patients. products LTB, and SHETE, the minor net eicosanoids 
The optimal concentration is l-2 FM. Consequently were the cyclooxygenase products HHT and TXB,. 
all following experiments were performed with 1 PM Other eicosanoids were less then 1.5% of 14C-AA which 
A23187. was converted per product. 
All eicosanoids formed from exogenous arachidonate To investigate if eicosanoid production from exo- 
by hp-Mo after A23187 stimulation are listed in Table genous and endogenous arachidonate were related to each 
Production of Inflammatorv Mediators bv Human Macroohaees Obtained from Ascites 187 
‘rable 2 Cytokine production by hp-Mo. IL-Ifi. IL-6 and TNF-a 
generation by IO6 hp-MO/ml stimulated for 24 h with IO pg/ml LPS. 
Data are expressed as mean f SEM and statistically analyzed by 
Student’\ I-WI 
Product Control LPS n 
____ 
IL- IB (ng/mll 3.0 f I .2 8.7 +_ 1.5* I6 
IL-6 (ng/ml) 6.1 5 1.3 32.6k 7.1* IO 
fh F-cc (ngiml) 0.1 Yk 0.1 2.7 k 1.1* IO 
19 killing 1 ‘116*t.l 41.7 k 3.9* I7 
tip < 0.05 (rncreasc vs controls). n = number of patients. 
Table 3tA I Eicoxanoid production from exogenous arachidonate 
hy hp-Ms. Profile of eicosanoid production from exogenous “C- 
arachidonic acid in IO’ hp-MO/ml after A23187 stimulation (I pM. 
I3 min. expressed as c/r of total formation per patient) 
Uct exogenous Net exogenous 
lipoxygenax cyclooxygenase 
products A23 I X7 (9 ) products A23 I87 (%,I n 
L’l B, 32.1 + 3.9* 6kPGF,,, 0.5 f 0.3 5 
5HETE 57.2 i 3.9* TXB, 7.6 + I.3 5 
di-HETE 1 .4 i 0.4 HHT 4.3 f 1.6 5 
I2HETE 0.3 * 0.z PCFzii 0.9 f 0.5 5 
IS~HETE 0.7 f 0.3 PGE, 0.1 k 0.04 5 
PGD, 0. I * 0. I 5 
*p < 0.05 (incrcasc vs controls). 
Table 3(B) Eicosanoid production from endogenous eicosanoid by 
hp-Mo. Eicosanoid production from endogenous arachidonate in 
IO hp-Ma/ml with and without A23187 stimulation (I yM, I3 min. 
sxoressed a\ ng/mll 
Control 
tngiml) 
Lipoxygena\e product 
LTB, I .o IL 0.3 
Cy clooxygcnaae product\ 
PGE, 0.1 io.1 
TXB 
6kP&,, 
I .I( i 0.2 
0.4 + 0.4 
‘I 1) < 0.05 trncrea\e vh control\). 
A23 I87 n 
(ng/ml) 
7.6 i 1.7” II 
0.24 f 0. I II 
I .8 k 0.3 5 
0.4 k 0.3 5 
other, four eicosanoids were measured in the same sam- 
ples by RIA, as in which “C-AA conversion was deter- 
mined by HPLC (Table 3b). The main eicosanoid was 
also a S-lipoxygenase product (LTB,). Cyclooxgenase 
production did not increase significantly with A23187. 
Furthermore eicosanoid production from endogenous 
arachidonate was measured in the same samples as in 
which the cytokine production was measured (24 h 
LPS). LPS did not significantly influence eicosanoid 
production from endogenous arachidonate over 24 h as 
measured by RIA (Table 4). 
Respiratory burst 
To measure the respiratory burst activity of the hp-Mo, 
the method published by Emmendorffer et al using 
di hydrorhodamine DHR 123 for human neutrophils (3 1) 
was modified for peritoneal Mo. The optima1 net for- 
EXOGENOUS 5-HETE 
0 1 2 3 4 5 
A231 87 (PM) 
EXOGENOUS LTB4 
25 
0 1 2 3 4 5 
A23187 (PM) 
ENDOGENOUS LTB4 
0 1 2 3 4 5 
A23187 (PM) 
Fig. 3 Eicosanoid formation from exogenous (top Fig: S-HETE. 
middle Fig; LTB,, 8 of total formation per patient) and endogenous 
arachidonate (bottom Fig; LTB,, ng/mll production of hp-Mo ( IOh/ 
ml). Cells were prelabeled with lJC-AA (2 mini. triggered with I pM 
A23 I87 for I3 min and ‘H labelled standards were added afterwards. 
The results of three patients are shown separately; (W. +. AI. 
mation of ROI loaded with (DHR 123) ((~1000 ng/ml, 
10 min) and stimulated with phorbol 12-myristate 13- 
acetate (TPA) (G-1000 ng/ml, 1.5 min) is given in Figure 4 
(top left and top right). All subsequent experiments were 
performed with 100 ng/ml TPA and 333 ng/ml DHR 
123. To check whether this method depended on the 
cell activity, the ROI production was also measured in 
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Table 4 Eicosanoid production from endogenous arachidonate by 
hp-Mb. Eicosanoid production from endogenous arachidonate in 
10h hp-MO/ml with LPS (10 p/ml. 24 h, expressed as &ml). LPS 
stimulation does not significantly (P < 0.05) stimulate eicosanoid 
production (vs controls) 
Control LPS n 
(ng/ml) (ng/ml) 
Lipoxygenase products 
LTB, I .o f 0.2 1.2 f 0.3 16 
Cyclooxygenase products 
PGEz I .7 + 0.3 2.1 f 0.2 16 
TXBz 3.4 * 0.3 3.2 f 0.2 5 
6kPGF,, 2.7 f 0.3 3.1 f 0.3 5 
cells (n = 4) which were kept on ice during the stimula- 
tion and loading (10 + 15 mins.). In Figure 4 (left bot- 
tom) the temperature dependency for the ROI production 
at 4°C (n = 4) and 37°C (n = 10) is shown. There was 
no significant ROI production increase at 4°C but TPA 
increased the net ROI production significantly at 37°C. 
The respiratory burst activity dependence on the time 
of stimulus is shown in Figure 4 (bottom right). The ROI 
production was significantly different after 15 min of 
stimulation. DHR 123 and TPA were given at the same 
time now. 
300 
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DISCUSSION 
Aim 
In previous experiments we have shown that ascites is 
a good source of hp-Mo which can be used to study 
eicosanoid production by human Mo (27, 28, 32). These 
Me, can be used as a model for testing the effects of 
anti-inflammatory drugs on the eicosanoid production 
in vitro, as we have shown previously with drugs such 
as malotilate (33) and E6080 (34). By gaining more 
information on the inter-relationships between the in- 
flammatory mediators, such as eicosanoids, cytokines 
and oxygen radicals of the hp-Me, we expect to expand 
our ex vivo anti-inflammatory drug testing model with 
human inflammatory cells. 
The aim of this study was to characterize in addition to 
the eicosanoid production other cell functions of hp-Mo 
including cytokine production and respiratory burst 
activity. 
Results 
We investigated the cytokine production of hp-Mo 
300 
. 
0 33.3 100 333.3 1000 
Dihydrorhodamlnel23 (ng/ml) 
-o- - TPA 
+ DHR 
-*- + TPA 
+ DHR 
* 
OL 
0.00 0.25 0.50 0.75 1 .oo 
Time (hours) 
Fig. 4 The radical oxygen intermediates (ROI) of hp-Mo (0.25 x IOh/ml) was measured with dihydrorhodamine 123 (DHR 123). Left top 
Figure shows the dependency of net ROI production on phorbol 12.myristate 13-acetate (TPA) concentration (@lo00 ng/ml. IO min TPA + 
15 min 333 ng/ml DHR 123.37”C, n = 3). Right top Figure shows the dependency of net ROI production on DHR 123 concentration (O- 
1000 ng/ml, 10 min 100 ng/ml TPA + 15 min DHR 123, 37°C. n = 3). The results of three patients are shown separately: (W, l , A). Left 
bottom Figure shows the spontaneous (open bar) and TPA-stimulated (closed bar) respiratory burst activity at 4°C (n = 4) versus 37°C 
(n = 10) (10 min blanc or 100 ng/ml TPA + 15 min 333 ng/ml DHR 123). In these 3 graphs the ROI production is given in mean channel 
number (MCN). Data are expressed as mean + SEM and statistically significant (*) when p < 0.05 vs controls (spontaneous respiratory 
burst). Right bottom Figure shows the stimulus time dependency (n = 3). Blanc (0) or TPA (0) and DHR 123 were given at the same time 
(t =0-I h, 100 ng/ml TPA, 333 ng/ml DHR 123.37”C. n = 3). The ROI production is expressed as % increase of maximal increase 
(=lOO%) per patient with TPA. Data are expressed as mean + SEM and statistically significant (*) when p < 0.05 vs controls (t = Oh). 
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stimulated with LPS as this is an important stimulus for 
Mo in vivo (7, 13). The eicosanoid production was de- 
termined both with LPS and A23 187 as this stimulus is 
known to be a potent trigger for lipoxygenase products 
derived from Mo (20, 21. 5). 
The experiments showed that the production of the 
cytokines IL-lb. IL-6 and TNF-a was LPS concentra- 
tion dependent and also dependent on the time of expo- 
\ure to the stimulus. LPS stimulation influenced the net 
IL-1 p, IL-6 and TNF-a production significantly, but 
did not have an appreciable effect on the eicosanoid 
production from endogenous arachidonate. A short 
stimulation with A23 187 gave a significant increase in 
lipoxygenase products from exogenous and endogenous 
arachidonate. The eicosanoid production from exo- 
genous and endogenous amchidonate depended on the 
.X3 187 concentration. 
Production of measurable amounts of ROI in vitro of 
the hp-Mo can be triggered by TPA. With the lowest 
concentration of the stimulating agent the ROI produc- 
tion was maximal. higher concentrations of TPA did 
not change the level of production. The measurement of 
ROI production was DHR 123 concentration dependent. 
Beyond 333 ng/ml the ROI production slightly de- 
creased. the DHR 123 concentration was no longer a 
limiting factor. With optimal concentrations of TPA and 
DHR 123 the net respiratory burst activity increased sig- 
nificantly. When stimulus and DHR 123 were given at 
the same time. the increase was significant after 15 min. 
Comparison of cytokine and eicosanoid production 
in MB from different species and/or origin 
Similar kinetics as we had found for LPS induced 
cytokine production have been previously reported for 
human alveolar Mo (35-37) hp-Mo obtained from con- 
tinuous ambulatory peritoneal dialysis (CAPD) patients 
I 3X, 39). a murine macrophage cell line (40) and murine 
peritoneal Mo (41, 43). In all these observations the 
;ytokine production increased with increasing LPS con- 
Lentration with a maximun in the range l-10 ug/ml LPS. 
Human alveolar Mo had with LPS a maximal IL-lb 
I O-43 h and IL-6 (O-72 h) production by 24 h (a slight 
increase at 72 h for IL-6) (35, 36). 
The IL-I production of the murine macrophage cell 
linz P388D 1 (e-1 8 h) and murine peritoneal Mo (Alderey 
Park, O-23 h) increased in time with LPS (40, 42). 
Peritoneal Mo from C3H/HEN and C3H/HEJ mice had 
lvith LPS (O-72 h) a maximal IL-I production at 24 h 
!-I ). The IL-6 production was maximal between 8-12 h 
tb~ the murine macrophage cell line (40). 
TNF-a production of Me, of other origin or species 
usually reached a maximal level at an earlier time than 
our hp-Mo. TNF-cx (W2 h) production of human al- 
vec)lar Mo peaked between 4-8 h (35). The murine 
macrophage cell line stimulated with LPS reached a pla- 
teau at 2 h (40). Rat peritoneal Mo reached a maximum 
at 6 h (44) and guinea pig peritoneal Mo around 8 h (45). 
In our experiments LTB4 and 5-HETE were the main 
eicosanoids formed (89%). when the Mo were stimu- 
lated with A23 187. In normal bovine alveolar Mo A23 187 
stimulated the release of both the cyclooxygenase and 
lipoxygenase products (21), also in resident mouse 
peritoneal Mo (46,47). Rat peritoneal Mo and rat Kupffer 
cells mainly synthesized cyclooxygenase products after 
A23 187 stimulation (32). 
In alveolar Me, from healthy volunteers. exogenous AA 
was predominantly metabolized via the S-lipoxygenase 
pathway (20, 48, 49). but also cyclooxygenase products 
were formed. when stimulated with A23 187 (20, 49). 
Leukotrienes are known to mediate inflammatory 
reactions. LTBl is an important chemotactic agent for 
leucocytes c 16), generates superoxide anion in neutro- 
phils ( 17). whereas the sulfidopeptide LTs (LTC,, LTDJ 
and LTE,) primarily affect smooth muscle contraction. 
increase vascular permeability ( 18 1 and promotes 
lysosomal enzymes (19). Specific inhibition of the en- 
zyme S-lipoxygenase has therapeutical potential in a 
variety of inf-lammatory conditions shown by different 
animal models and clinical trials (50-52) and as men- 
tioned before we have tested the drugs malotilate (33) 
and E6080 (34) on the eicosanoid production in our in 
vitro model. 
The pattern of eicosanoid metabolism depends on the 
stimulus applied (30, 21, 48). as well as the maturity of 
the cell (49), site of origin of macrophage and the spe- 
cies (32). In relation to this, in vivo priming might be 
another important point for influencing the eicosanoid 
and cytokine profile when the cells are stimulated in 
vitro. Cytokines and eicosanoids also regulate their own 
and each other’s release in vivo and in vitro (53-55). 
The exact interaction of these mediators involved in 
human macrophage inflammation still has to be 
investigated. 
Comparison of cytokine and eicosanoid production 
in hp-M@ from liver cirrhosis and CAPD patients 
The high cytokine production of our hp-Mo with LPS 
was probably due to priming of the cells in vivo. The 
patients, where the cells were isolated from. have a 
chronic inflammation. Peritoneal Mo obtained from 
CAPD patients during peritonitis and compared to Mo 
obtained from the same type of patients during an infec- 
tion free period, stimulated with LPS in vitro, released 
significantly more IL- I p and TNF-a (39. 56) whereas 
their prostacyclin release (measured as 6kPGF,,,. with- 
out and with LPS) had declined sharply (38 j. 
The TNF-cx bioactivity of the liver cirrhosis Mo seems 
lower then Ms of CAPD patients with peritonitis. how- 
ever TNF-a was measured by different bioassay\. Al- 
though the methods are comparable the % killing is higher 
with the ‘H-thymidine incorporation cytostatic assay 
compared to the MTT tetrazolium cytotoxic assay (29). 
Therefore the TNF-cx bioactivity of hp-Mo, from liver 
cirrhosis patients compared to Mo from CAPD patients 
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with peritonitis could be in the same range. The concen- 
trations of TNF-a measured by ELISA in supematants 
of liver cirrhosis patients however showed a TNF-a pro- 
duction comparable to M@s from CAPD patients without 
peritonitis. 
A pronounced difference between the MO from liver 
cirrhosis and the Ma of CAPD patients with peritonitis 
was observed in the PGE? production. The PGE? release 
of human peritonitis MO without LPS was initially much 
higher than the hp-Mp, in our observations. Furthermore 
a significant increase in PGEz production in response to 
LPS was seen (no difference compared to infection-free 
MO of CAPD patients). In conclusion the M@s of liver 
cirrhosis patients have striking features with M@s from 
CAPD patients with peritonitis (Table 5). 
Oxygen radical production 
In response to TPA the ability to generate oxygen radi- 
cals was enhanced. TPA stimulates the intracellularly 
and extracellularly respiratory burst of phagocytes (57, 
58). The flow cytometric method we have used here 
reflects the total production of H202 inside single, stimu- 
lated, cells. DHR 123 is oxidized by a hydrogen perox- 
ide and peroxidase dependent system. This method with 
DHR 123 seemed to be a highly sensitive indicator for 
the respiratory burst (59-61). In comparison with human 
monocytes and neutrophils the respiratory burst of 
monocyte-derived MO was very low when measured 
with the luminol-amplified chemiluminescence assay 
(61). which measures intra- and extracellular H201 and 
O’- (58). We were able to measure with DHR 123 a clear 
increase in the respiratory burst activity, when the MO 
were stimulated with TPA. Our results were similar to 
Banati (30) whom measured the respiratory burst of rat 
peritoneal MO with DHR 123. The MO exhibit spontane- 
ous respiratory burst activity before stimulation and after 
stimulation the fluorescence intensity had increased 
about a factor 3. our ROI production (in MCN) increased 
a factor 2.4. 
Table 5 Comparison of cytokine and PC synthesis by human 
peritoneal macrophages from liver cirrhosis and CAPD patients 
without and with peritonitis. Compared are the eicosanoid and 
cytokine synthesis without stimulus (24 h PBS = blancs) and with 
stimulus (24 h LPS = LPS). LPS = 5 pg/ml CAPD hp-Md (IOh cells/ 
ml) and 1 Opg/ml with liver cirrhosis hp.M@ (I 0” cells/ml). 
n = number of patients 
Liver cirrhosis (this study) n CAPD (38, 39,56) 
Control n Peritonitis n 
IL-1p blancs 3.0+ 1.2 16 0.3+0.1 9 0.2*0.1 8 
(ngimll LPS 8.7 * 1.5 I .o + 0.2 6.6 + 2.8 
TNF-a blancs 21.6i 5.1 I7 4.3 k5.l 21 12.9k4.1 12 
(c/c killing) LPS 47.7 f 3.9 15.8 f 6.5 61.9 + 7.7 
TNF-a blancs 0.1 kO.1 IO l.Of0.3 I7 1.0 + 0.3 12 
(ngiml) LPS 2.7 * 1.1 2.6 i 0.4 9.3 * 4.3 
6kPGF,, blancs 2.7 * 0.3 5 19.1 & 3.6 10 3.4 * 1.4 IO 
(ng/mJ) LPS 3.1 + 0.3 21.4 & 4.3 4.0 * 1.2 
PGE? blancs 1.7 * 0.3 5 15.1 + 2.7 IO 9.4? 2.6 IO 
LPS 2.1 * 0.2 27.4 + 4.5 3l.Ok4.4 
Conclusion 
Ascitic fluid is an easily available source of large quanti- 
ties of hp-MO. In this study we have characterized the 
eicosanoid and cytokine production and respiratory burst 
activity of human MO isolated from peritoneal ascitic 
fluid. The IL-lb, IL-6 and TNF-or kinetics of hp-MO 
stimulated with LPS is similar to that of human lung MO, 
peritoneal Me of CAPD patients and peritoneal Mp, of 
other species. The cytokine production is LPS concen- 
tration dependent and dependent on the time of exposure 
to LPS. The profile of eicosanoid production depends on 
both the species origin, location and the stimulus ap- 
plied. LPS did not effect the eicosanoid production from 
endogenous arachidonate of the hp-MB, while a stimula- 
tion with A23187 both increased the lipoxygenase pro- 
duction from exogenous and endogenous arachidonate. 
The MO of liver cirrhosis patients have striking features 
with Me from CAPD patients with peritonitis, probably 
due to priming of the Me, in vivo. 
With optimal concentrations of TPA and DHR 123 
the net respiratory burst activity in the hp-M# increased 
significantly. Whether a relation exists between forma- 
tion of cytokines and eicosanoids and the respiratory 
burst activity of the hp-M@ still has to be examined. 
Characterization of hp-M@ function show that ascites 
may be a promising source of MO to set up a model for 
testing the effects of anti-inflammatory drugs in vitro on 
different types of inflammatory mediators produced by 
human Mei. 
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